Bondi is advising a listed life science company in the Øresund region that is approaching a decisive strategic phase. The company is backed by a long term, life science focused owner with a strong track record of building and scaling listed companies.

The company operates in advanced therapeutics, built around a proprietary technology platform with assets that have reached early clinical validation. The next phase is strongly driven by partnerships, licensing and capital strategy.

The board is seeking a CEO with a proven ability to structure and close transactions with international industry partners and investors. Experience from listed environments and complex stakeholder settings is essential.

If you are a commercially driven leader with a strong dealmaking track record and are open to a confidential discussion, please reach out directly.